BioDelivery Sciences (BDSI) Misses Q4 EPS by 3c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/2/2026
- S&P 500 rises; Apple and Palantir set to report results
- Marvell agrees $115 billion all-stock deal to buy Lumentum
- Oil drops 7% as Iran signals openness to peace talks
- Why has the market become so unforgiving of AI earnings?
- EchoStar rises on report SpaceX in talks to buy Boost Mobile or tap its network
Tweet
Share
E-mailGet Alerts BDSI Hot Sheet
Price: $5.59 --0%
Financial Fact:
Research and development: 4.4M
Today's EPS Names:
LTBR, AES, SYRS, More
Financial Fact:
Research and development: 4.4M
Today's EPS Names:
LTBR, AES, SYRS, More
Join SI Premium – FREE
BioDelivery Sciences (NASDAQ: BDSI) reported Q4 EPS of ($0.29), $0.03 worse than the analyst estimate of ($0.26). Revenue for the quarter came in at $3.9 million versus the consensus estimate of $3.88 million.
For earnings history and earnings-related data on BioDelivery Sciences (BDSI) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Marriott (MAR) Tops Q3 EPS by 19c; Guides EPS Higher
- AbbVie (ABBV) Tops Q3 EPS by 8c, Offers Guidance
- Information Services Group (III) Tops Q3 EPS by 4c ; Offers Guidance
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
